Establishing secure connection…Loading editor…Preparing document…

Materials Transfer Release

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

Materials Transfer Release

This Materials Transfer Release (the Agreement) is entered into as of by and between Provider Name: and Recipient Name: .

WHEREAS

WHEREAS, Provider has certain materials, samples, components, or prototypes described below (the Materials) that Provider is willing to transfer to Recipient solely for the Purpose set forth herein and subject to the terms and conditions of this Agreement.

WHEREAS, Recipient desires to accept the Materials for the limited Purpose and represents that Recipient has the facilities, personnel, permits, and expertise necessary to handle, store, and use the Materials in accordance with applicable laws and the terms of this Agreement.

WHEREAS, the parties intend by this Agreement to allocate responsibility for possession, use, return or destruction, and risk of loss for the Materials, and to address confidentiality, liability, and regulatory compliance.

MATERIALS DESCRIPTION

Item 1

Item 2 (if applicable)

SCOPE OF WORK

Recipient shall use the Materials only for the purpose described below and shall not use the Materials for human administration, clinical use, resale, or any other purpose not expressly authorized in writing by Provider.

PAYMENT TERMS

Unless otherwise agreed, Recipient shall pay Provider the consideration set forth below for preparation, handling, and transfer of the Materials.

TERM AND TERMINATION

This Agreement commences on the Start Date below and continues until the End Date below or until terminated in accordance with this section.

Either party may terminate this Agreement for material breach if the breaching party fails to cure within the notice period set forth above. Termination shall not relieve Recipient of obligations with respect to Materials already transferred, including disposal, confidentiality, indemnity, and payment for services performed.

CONFIDENTIALITY

Recipient shall treat as Confidential Information any nonpublic information provided by Provider in connection with the Materials, including composition, process information, test data, and technical specifications. Recipient shall not disclose Confidential Information to any third party except to personnel who have a need to know and are bound by written confidentiality obligations no less protective than those in this Agreement. Confidentiality obligations shall survive termination or expiration of this Agreement for years, provided that trade secrets shall remain protected for as long as they qualify as trade secrets under applicable law.

USE, HANDLING, AND COMPLIANCE

Recipient shall handle, store, transport, and dispose of the Materials in accordance with all applicable laws, regulations, and industry standards. Recipient shall not use the Materials for human clinical applications unless prior written approval is provided by Provider and all required regulatory approvals have been obtained by Recipient.

Provider declares that the Materials include hazardous substances requiring special handling

If hazardous, Provider will supply appropriate safety data sheets and handling instructions prior to shipment; Recipient must confirm receipt of such materials and instructions in writing.

OWNERSHIP; LICENSES

Title to the Materials remains with Provider. Recipient receives only physical possession of the Materials and a limited, nontransferable license to use the Materials solely for the Purpose. No rights in Provider's patents, copyrights, or confidential know-how are conveyed except as expressly set forth in writing.

WARRANTIES; LIABILITY; INDEMNIFICATION

Provider warrants only that, to the best of Provider's knowledge, the Materials conform to the description provided at the time of transfer. EXCEPT FOR THE LIMITED WARRANTY STATED ABOVE, THE MATERIALS ARE PROVIDED "AS IS" WITHOUT OTHER WARRANTIES, EXPRESS OR IMPLIED, INCLUDING WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE.

Recipient shall indemnify, defend, and hold harmless Provider and its officers, employees, and agents from and against any claims, liabilities, losses, and expenses (including reasonable attorneys' fees) arising out of Recipient's use, storage, handling, or disposal of the Materials, breach of this Agreement, or violation of law. Provider's liability to Recipient for any claim arising out of this Agreement shall not exceed the amount paid by Recipient to Provider under this Agreement for the Materials at issue.

RETURN OR DESTRUCTION

Upon expiration or termination, or upon Provider's written request, Recipient shall (at Provider's option) return all unused Materials to Provider or destroy such Materials and certify in writing to Provider that destruction has been completed in accordance with applicable regulations and Provider's instructions.

GOVERNING LAW

This Agreement shall be governed by and construed in accordance with the laws of the State of without regard to conflict of laws principles. Venue for any dispute shall lie in the state or federal courts located in that State, and the parties consent to personal jurisdiction therein.

ENTIRE AGREEMENT

This Agreement constitutes the entire agreement between the parties with respect to the subject matter hereof and supersedes all prior and contemporaneous agreements, proposals and communications, whether oral or written. No amendment or waiver shall be effective unless in writing and signed by an authorized representative of each party.

MISCELLANEOUS

If any provision of this Agreement is held invalid or unenforceable, the remaining provisions shall remain in full force and effect. Neither party may assign this Agreement without the prior written consent of the other, except that Provider may assign to an affiliate or successor in connection with a merger or sale of substantially all of its assets.

Provider:

By:

Date:

Recipient:

By:

Date:

Enter text✕
Prepare your document for signing right on this page
  • 01 Edit the text and complete the fields
  • 02 Click Sign Now and on the next screen add recipients and signature fields in SignNow
  • 03 Start your free trial to sign and send your doc
Sign Now

What a Materials Transfer Release Is

Materials Transfer Release is a legal document used to record the transfer of physical or biological materials, samples, or proprietary components between parties. It specifies the items transferred, permitted uses, custody and chain-of-custody obligations, liability allocation, disposal instructions, and any intellectual property or confidentiality terms. In the United States, these releases are governed by contract law and can be executed electronically when parties satisfy ESIGN (15 U.S.C. ch. 96) and applicable state UETA rules. Parties should document provenance and retention to support regulatory, clinical, or research audits.

Why a Clear Release Matters

Materials Transfer Releases clarify responsibilities, reduce liability, and preserve chain-of-custody for samples and proprietary items. They enable institutions to set permitted uses, confidentiality, and disposal terms. When executed electronically under ESIGN and UETA, they are enforceable in most U.S. jurisdictions.

Why a Clear Release Matters

Common users and organizational roles

Typical users who complete Materials Transfer Releases include research labs, clinical sites, technology transfer offices, and third-party service providers.

  • Academic researchers and university labs managing biological or chemical sample exchanges.
  • Clinical trial sites transferring patient samples under protocol and consent restrictions.
  • Corporate R&D or CROs sharing proprietary materials under confidentiality terms.

Organizations of varying size use these releases to document approvals, responsibilities, liability limitations, and permitted future uses.

Who signs and why

Transferor Representative

A lab manager or institutional official authorized to approve material releases, confirm sample descriptions and ensure compliance with institutional biosafety and export-control policies. This person typically verifies chain-of-custody procedures, signs the release, and retains a copy for institutional records and audits.

Recipient Representative

An authorized recipient contact, such as a principal investigator or procurement officer, who accepts custody, acknowledges permitted uses, and documents receipt. This signer confirms storage, handling and disposal responsibilities and provides identification information required for legal and regulatory traceability.

Typical compliance and security features to expect

Encryption (Transit): TLS 1.2 and 1.3 protocols
Encryption (At Rest): AES-256 encryption for stored data
Audit Trails: Detailed timestamps, IP addresses and action history
Certifications: SOC 2 Type II and ISO 27001
HIPAA Support: BAA available for covered entities
FDA Records: 21 CFR Part 11 compliance features

Quick risks and legal consequences

Filing Penalties: IRC §6721 penalties apply
Contractual Liability: Breach damages and indemnities
Research Compliance: Audit findings and funding risks
Privacy Violations: HIPAA exposure and penalties
Chain-of-Custody Gaps: Evidence inadmissible in disputes
Notarization Missing: May void documents in narrow cases

Common preparation pitfalls to avoid

  • Using vague material descriptions (for example, 'sample set') that fail to identify source, concentration, or container can cause custody disputes and regulatory noncompliance.
  • Leaving the effective date blank or using inconsistent date formats complicates enforcement and can affect applicable statutory limitation periods and audit timelines.
  • Allowing unauthorized staff to sign releases or failing to verify authority increases the risk of later invalidation and costly contractual disputes.
  • Not documenting special handling, biosafety level, or disposal instructions can lead to safety incidents, regulatory citations, and potential liability.

Step-by-step: completing a Materials Transfer Release

Follow these steps to complete a Materials Transfer Release accurately and maintain legal and regulatory traceability.

  • 01
    Prepare Document: Identify materials, purpose, and parties before drafting.
  • 02
    Describe Materials: List species, quantity, concentration, and container specifics.
  • 03
    Assign Use Terms: Specify permitted uses, sublicensing, and IP allocations.
  • 04
    Sign and Store: Obtain authorized signatures, date, and retain copies securely.

How a transfer typically proceeds

Typical routing for a transfer: request, institutional review, release authorization, physical transfer, and record retention.

  • Request: Initiated by requestor with material details and purpose.
  • Review: Institutional compliance or biosafety review approves transfer.
  • Authorize: Authorized signers execute the Materials Transfer Release.
  • Transfer: Ship or deliver items with chain-of-custody documentation.

Core elements a professional release should include

A professional Materials Transfer Release organizes obligations, identifies parties, and documents custody, permitted uses, confidentiality, indemnity, and disposal instructions for legal clarity and operational safety.

Parties

Identify transferor and recipient including institutional affiliations, department, contact details, and authority-to-sign. Clear party identification prevents later disputes and supports auditability during inspections or regulatory review.

Material Details

Provide precise description: species, strain or lot numbers, quantity, concentration, storage conditions, container type, and unique identifiers. Accurate descriptions preserve traceability and reduce handling errors.

Permitted Uses

Specify exact permitted uses, any prohibitions, duration of use, and sublicensing rights. Narrow, explicit use terms reduce IP conflicts and ensure compliance with consent or export-control restrictions.

Confidentiality

Detail non-disclosure obligations, access limitations, and required handling of proprietary information. Include obligations for third-party disclosures and reasonable measures to protect trade secrets and sensitive data.

Liability

Allocate risk through indemnity, warranty disclaimers, and insurance requirements. State responsibilities for contamination, loss, or misuse and practical limitations on damages consistent with governing law.

Disposition

Provide end-of-use disposal instructions, return versus destruction options, and documentation required for destruction. Include evidence requirements for compliance and acceptable disposal methods for hazardous materials.

Configuring an online materials transfer workflow

Configure an online workflow to collect approvals, attach chain-of-custody documentation, and capture legally admissible signatures.

Field Configuration
Signer Authentication Email, SMS code, or KBA
Conditional Fields Show handling fields when hazardous selected
File Attachments Require COA, protocol, and approvals
Retention Policy Set document retention and export options

Platform and technical considerations

Use platforms that support secure e-signature, audit trails, and attachments for materials documentation.

  • File Types: PDF, DOCX accepted
  • Integrations: NetSuite, Salesforce, Google Workspace
  • Authentication: Email, SMS, SAML options

Timelines and expected processing windows

Materials Transfer Releases have no single federal filing deadline, but timing matters for regulatory and project milestones.

Request Response Time:

Typical institutional review completes within 5–15 business days.

Shipping Window:

Shipments often scheduled within 3–10 business days after approval.

Record Retention Start:

Retention begins on the effective date of the release.

Destruction Confirmation:

Recipient must provide proof of destruction on agreed schedule.

Urgent Transfers:

Expedited workflows may complete within 24–48 hours.

Representative eSignature pricing and capability comparison

Representative pricing and feature indicators to consider for Materials Transfer Releases; signNow appears first to show its entry-level pricing and capabilities.

signNow DocuSign Adobe Sign PandaDoc HelloSign
Starting Price $8/user/mo $15/user/mo $14/user/mo $19/user/mo $15/user/mo
Free Trial 7-day free trial Varies by plan Varies by plan Varies by plan Varies by plan
Bulk Send Yes Yes Yes Yes No
Audit Trail Yes Yes Yes Yes Yes
Envelope Cap No cap 100 envelopes/user/year Varies by plan Varies by plan Varies by plan

Real-world examples of materials transfer workflows

Case examples illustrate how organizations streamline approvals and maintain compliant records for material exchanges.

Optica Ventures

Optica Ventures needed a simpler way to authorize material transfers to contract labs and CROs.

  • The team required clear chain-of-custody and reusable templates.
  • Brian Fitzgibbons, COO, said the interface is simple and easy to use, helping external partner sign-off and improving operational throughput.

Xerox

Xerox automated transfers and integrated sign workflows with back-office systems to reduce manual steps.

  • Integration with enterprise systems shortened handoffs and improved tracking.
  • Kodi-Marie Evans, Director of NetSuite Operations, noted flexibility to get signatures on the right documents and formats based on integration needs.

Key processing milestones for a materials transfer

Typical milestone stages for a Materials Transfer Release from request through records closure.

01

Request Submitted

Requestor provides material details and intended use for initial review.

02

Institutional Review

Compliance, biosafety, and legal teams review and approve transfer conditions.

03

Release Execution

Authorized signers sign release and record effective date and conditions.

04

Transfer Closed

Items transferred, chain-of-custody documented, and records archived per retention policy.

Practical tips for accurate and efficient completion

Adopt standard practices to reduce errors, accelerate approvals, and strengthen defensible documentation.

Use precise identifiers and attachments
Include lot numbers, serials, container IDs, and attach COAs or protocols directly to the release to prevent mismatches and support audits without costly follow-up requests.
Define permitted uses and IP clearly
Spell out allowed experiments, commercialization restrictions, and who may sublicense materials; ambiguous use clauses create downstream intellectual property disputes during collaborations or publications.
Verify signer authority before finalizing
Confirm signers are authorized institutional agents; require title and department in the signature block to avoid later claims that an agreement was unsigned or invalid.
Preserve chain-of-custody evidence
Record timestamps, shipment tracking, receipt acknowledgments, and environmental conditions when required; maintain those records for the retention period to support regulatory or legal review.

Frequently asked questions about Materials Transfer Releases

Answers to common legal and operational questions about creating, signing, and storing Materials Transfer Releases.


Need help? Contact support

be ready to get more
Join over 28 million airSlate SignNow users
Sign Now
Company
Forms
Pricing
Resources
Knowledge base
Other Products
© 2026 airSlate Inc. All rights reserved.